Long-Term Outcomes Associated with NAFLD, ASCVD, and All-Cause Mortality of Patients with Metabolic Syndrome

Metabolic syndrome (MetS) patients are at higher risk for nonalcoholic fatty liver disease (NAFLD), atherosclerotic cardiovascular diseases (ASCVD), and death. Given a lack of longitudinal data on patients with MetS in Southeast Asia, this study investigated the incidence of NAFLD and ASCVD and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jitrukthai, Suchanart, Kositamongkol, Chayanis, Boonchai, Punyisa, Mepramoon, Euarat, Ariyakunaphan, Pinyapat, Nimitpunya, Pongpol, Srivanichakorn, Weerachai, Chaisathaphol, Thanet, Washirasaksiri, Chaiwat, Auesomwang, Chonticha, Sitasuwan, Tullaya, Tinmanee, Rungsima, Sayabovorn, Naruemit, Charatcharoenwitthaya, Phunchai, Phisalprapa, Pochamana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370024/
https://www.ncbi.nlm.nih.gov/pubmed/35956240
http://dx.doi.org/10.3390/jcm11154627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370024/
https://www.ncbi.nlm.nih.gov/pubmed/35956240
http://dx.doi.org/10.3390/jcm11154627

Ejemplares similares